{"denoms":[{"counts":[{"groupId":"BG000","value":"330"}],"units":"Participants"}],"groups":[{"description":"Pharmacists included in Nikkei Medical Online Panel, active in clinical practice, and with valid contact details who belonged to hospitals and have instructed the dosing of NINLARO (ixazomib) in combination with lenalidomide and dexamethasone (IRD therapy) to patients were selected to participate in the survey.","id":"BG000","title":"Pharmacists in Hospitals Prescribing NINLARO"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"330"}]}],"title":"Greater than or equal to (>=) 22 years"}],"description":"Here, unit of measure: participants refer to pharmacists.","paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"198"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"132"}],"title":"Male"}]}],"description":"Here, unit of measure: participants refer to pharmacists.","paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"330"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Unknown or Not Reported"}]}],"description":"Here, unit of measure: participants refer to pharmacists.","paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"330"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Unknown or Not Reported"}]}],"description":"Here, unit of measure: participants refer to pharmacists.","paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"330"}]}],"title":"Japan"}],"description":"Here, unit of measure: participants refer to pharmacists.","paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"}],"populationDescription":"The final analysis set included all pharmacists who consented to participate in the survey, passed the screening questions, and completed all questions."}